Lundbeck ready to take Genmab antibody to phase II
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13437155.ece/ALTERNATES/schema-16_9/20160614-073059-L-1920x1079we.jpg)
After an 11-year collaboration, the Danish alliance between Genmab and Lundbeck has reached another clinical milestone, according to the database Clinical Trials, which collects information about research studies.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Genmab upgrades financial guidance again
For subscribers